| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.36 | 0.002 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.003 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |